Thermopylae Holdings Ltd.'s Form 4 filing
AbCellera Biologics Inc. (ABCL) · filed Jun 15, 2022
- Accession no.
- 0001209191-22-036884
- Filed
- Jun 15, 2022
- Trade date
- Jun 13-14, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $514.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thermopylae Holdings Ltd.CIK 0001834449 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2022 | Common Shares | PPurchaseAcquired | +54,915 | $8.03 | +$440,967.45 | 55,635,218 | Direct | |
| Jun 14, 2022 | Common Shares | PPurchaseAcquired | +9,173 | $8.05 | +$73,842.65 | 55,644,391 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.